Showing results (381-390 of 632) with videos related to
Sort By:
Pageof 64
Human Vaccines|July 12, 2007
Trust and experience as predictors of HPV vaccine acceptanceLaura A V Marlow, Jo Waller, Jane WardleHuman Vaccines|July 20, 2007
Vaccination and risk groups: how can we really protect the weakest?Paolo BonanniHuman Vaccines|September 21, 2007
Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines?Alberto E Tozzi, Chiara Azzari, Giorgio Bartolozzi, et al.Human Vaccines|October 13, 2006
Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysisM K Sudarshan, B J Mahendra, S N Madhusudana, et al.Human Vaccines|October 3, 2006
Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primatesCheryl H Dean, Jason B Alarcon, Andrea M Waterston, et al.Human Vaccines|October 3, 2006
The natural history of untreated HIV infection in Lima, Peru: implications for clinical trial endpoints for HIV vaccinesDaniel Corey, Hyung Woo Kim, Raul Salazar, et al.Human Vaccines|October 3, 2006
Follow-up of MMR vaccination status in children referred to a pediatric immunization clinic on account of egg allergyFelicity Goodyear-Smith, Fleur Wong, Helen Petousis-Harris, et al.Human Vaccines|October 3, 2006
Canadian Association for Immunization Research and Evaluation (CAIRE) guidelines for industry-sponsored clinical trial and epidemiology contract researchScott A Halperin, David Scheifele, Bernard Duval, et al.Human Vaccines|October 3, 2006
Applications of influenza virosomes as a delivery systemMaria Grazia CusiHuman Vaccines|August 12, 2008
Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccines administered at 3, 5 and 11-12 months of ageTerhi M Kilpi, Sven Arne Silfverdal, Lennart Nilsson, et al.Pageof 64